Please Join the NAVBO Journal Club!! Thursday, June 19th at 1pm ET An activin receptor-like kinase 1 - governed monocytic lineage shapes an immunosuppresive landscape in breast cancer metastases By Kate Alexander, University of Illinois Paper: tinyurl.com/mpk58998 Event: tinyurl.com/y2p5xp5y

#ICYMI our deep dive into ALK1 biology, at the intersection between angiogenesis and immunology with clear implication for the targeting of immunomodulatory cues & cancer therapy!

Journal of Clinical Investigation@jci.org · last yr.

Targeting the most immune-suppressive macrophage with ALK1 inhibitors in malignant breast cancer! @kpietraslab.bsky.social & team @lund-university.bsky.social target the most immune-suppressive macrophage with ALK1 inhibitors in malignant breast cancer models! buff.ly/FXssb1x

So much pride, so much joy! ❤️ @kpietraslab.bsky.social

Kristian Pietras – Årets cancerforskare 2025

Kristian Pietras forskar om hur celler i blodkärl och bindväv påverkar cancerns möjlighet att växa eller dö. Nu tilldelas han utmärkelsen Årets cancerforskare.

cancerfonden.se

Incredible skills, knowledge, endurance, passion, and joy went into the making of this study by main authors @matteobocci.bsky.social, Mehrnaz Safaee-Talkhoncheh, and Jonas Sjölund. We also thank all co-authors, and especially acknowledge the work of undergraduate and graduate students. 5/6

We have been waiting impatiently but can finally share our latest efforts in understanding the biology of the TGF-beta type I receptor ALK1 (gene name ACVRL1), see graphical abstract in post and the full article here: www.jci.org/articles/vie... 1/6

What were the most inspiring 2024 discoveries in cancer? Cancer Discovery asked me, Katherine Aird, Aadel Chaudhuri, Jennifer Guerriero, Shiri Gur-Cohen, Benjamin Izar, Brittany Jenkins, Delphine Merino, Alejo Rodriguez-Fraticelli & Shensi Shen, & here's what we said aacrjournals.org/cancerdiscov...